AHUS

Clinical trials for AHUS explained in plain language.

Never miss a new study

Get alerted when new AHUS trials appear

Sign up with your email to follow new studies for AHUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for controlling rare blood disorder that attacks kidneys

Disease control Recruiting now

This study is testing how well the drug ravulizumab works to control atypical hemolytic uremic syndrome (aHUS), a rare disease where the immune system attacks blood cells and damages kidneys. The research will follow 20 participants for 26 weeks to see if the treatment improves t…

Matched conditions: AHUS

Phase: PHASE4 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

AHUS

Get alerted when new AHUS trials appear

New hope for controlling rare blood disorder that attacks kidneys